articleThe LancetNov 9, 2017GREEN OA

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

DLDavid L. KendlerFMFernando MarínCACristiano A. F. ZerbiniLALuis Augusto Tavares RussoSLSusan L. Greenspan

University of British Columbia · Eli Lilly (Spain) · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

572
total citations
FWCI
39.95
Percentile
100%
References
30
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Teriparatide
  • Medicine
  • Osteoporosis
  • Placebo
  • Surgery
  • Hazard ratio
  • Bone mineral
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding